Our lawyers advise leading issuers, investment banks and investors in equity and debt transactions that raise capital through the global public and private capital markets. We are the most active law firm for technology and life sciences IPOs. We have a unique industry leading company-side as well as bank-side practice, giving us deep insights in the capital markets sector. We are pragmatic, commercially minded capital markets lawyers who not only appreciate relevant legal considerations, but also deeply understand our clients’ businesses and are focused on helping them attain their marketing, positioning and transactional objectives. Our collaborative team-based approach makes us the preferred choice as either issuer's counsel or underwriters' counsel on many of the most trans-formative capital markets transactions.